Drug Shortage Report for FUROSEMIDE INJECTION USP
| Report ID | 163468 |
| Drug Identification Number | 02461404 |
| Brand name | FUROSEMIDE INJECTION USP |
| Common or Proper name | FUROSEMIDE INJECTION USP 40 MG/4ML |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FUROSEMIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 VIALS |
| ATC code | C03CA |
| ATC description | HIGH-CEILING DIURETICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-27 |
| Estimated end date | 2022-07-29 |
| Actual end date | 2022-08-04 |
| Shortage status | Resolved |
| Updated date | 2022-08-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-06-27 | English | Compare |
| v2 | 2022-06-27 | French | Compare |
| v3 | 2022-06-28 | English | Compare |
| v4 | 2022-08-04 | English | Compare |
| v5 | 2022-08-04 | French | Compare |
| v6 | 2022-08-05 | English | Compare |
Showing 1 to 6 of 6